UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Aberrant Methylation during Cervical Carcinogenesis

Clinical cancer research, 2001-03, Vol.7 (3), p.584-589

2001

Volltextzugriff (PDF)

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Blood, 2021-03, Vol.137 (12), p.1669-1678

2021

Volltextzugriff (PDF)

Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer

British journal of haematology, 2019-07, Vol.186 (2), p.311-320

2019

Volltextzugriff (PDF)

Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality

Heart (British Cardiac Society), 2015-12, Vol.101 (23), p.1874-1880

2015

Volltextzugriff (PDF)

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

Cancer cell, 2013-08, Vol.24 (2), p.167-181

2013

Volltextzugriff (PDF)

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

Blood, 2015-01, Vol.125 (1), p.90-101

2015

Volltextzugriff (PDF)

Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non–small cell lung cancer brain metastases

Cancer, 2020-10, Vol.126 (19), p.4341-4352

2020

Volltextzugriff (PDF)

The impact of COVID‐19 on cancer care of outpatients with low socioeconomic status

International journal of cancer, 2022-07, Vol.151 (1), p.77-82

2022

Volltextzugriff (PDF)

Influence of temporal muscle thickness on the outcome of radiosurgically treated patients with brain metastases from non-small cell lung cancer

Journal of neurosurgery, 2022-10, Vol.137 (4), p.999-1005

2022

Volltextzugriff (PDF)

Lung cancer: From single-gene methylation to methylome profiling

Cancer and metastasis reviews, 2010-03, Vol.29 (1), p.95-107

2010

Volltextzugriff (PDF)

Homeopathic Treatment as an Add‐On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non‐Small Cell Lung Cancer: A Prospective, Randomized, Placebo‐Controlled, Double‐Blind, Three‐Arm, Multicenter Study

The oncologist (Dayton, Ohio), 2020-12, Vol.25 (12), p.e1930-e1955

2020

Volltextzugriff (PDF)

Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer

Cancers, 2020-06, Vol.12 (6), p.1619

2020

Volltextzugriff (PDF)

Non-interventional LUME-BioNIS study of nintedanib plus docetaxel after chemotherapy in adenocarcinoma non-small cell lung cancer: A subgroup analysis in patients with prior immunotherapy

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.159-165

2020

Volltextzugriff (PDF)

SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness

Scientific reports, 2019-06, Vol.9 (1), p.9139-13, Article 9139

2019

Volltextzugriff (PDF)

Lung Cancer in Austria

Journal of thoracic oncology, 2021-05, Vol.16 (5), p.725-733

2021

Volltextzugriff (PDF)

DNA methylation of microRNA‐coding genes in non‐small‐cell lung cancer patients

The Journal of pathology, 2018-08, Vol.245 (4), p.387-398

2018

Volltextzugriff (PDF)

Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non―Small Cell Lung Cancers

Clinical cancer research, 2012-03, Vol.18 (6), p.1619-1629

2012

Volltextzugriff (PDF)

Neutrophil-to-Lymphocyte Ratio Is Superior to Other Leukocyte-Based Ratios as a Prognostic Predictor in Non–Small Cell Lung Cancer Patients with Radiosurgically Treated Brain Metastases Under Immunotherapy or Targeted Therapy

World neurosurgery, 2021-07, Vol.151, p.e324-e331

2021

Volltextzugriff (PDF)

Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients

Journal of neuro-oncology, 2021-01, Vol.151 (2), p.257-265

2021

Volltextzugriff (PDF)

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation

Frontiers in oncology, 2021-01, Vol.10, p.593852

2021

Volltextzugriff (PDF)

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

Cancer cell, 2016-08, Vol.30 (2), p.359-360

2016

Volltextzugriff (PDF)

Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort

Journal of neuro-oncology, 2019-10, Vol.145 (1), p.85-95

2019

Volltextzugriff (PDF)

Homeopathic Treatment as an Add‐On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non‐Small Cell Lung Cancer: A Prospective, Randomized, Placebo‐Controlled, Double‐Blind, Three‐Arm, Multicenter Study

The oncologist (Dayton, Ohio), 2021-03, Vol.26 (3), p.e523-e523

2021

Volltextzugriff (PDF)

Genome-Wide Transcriptional Response to 5-Aza-2'-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells

Cancer research (Chicago, Ill.), 2008, Vol.68 (1), p.44-54

2008

Volltextzugriff (PDF)

Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery

Journal of surgical oncology, 2017-08, Vol.116 (2), p.227-235

2017

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(70)

Sprache

Englisch
(65)
Japanisch
(11)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(58)
Oncology
(45)
Humans
(42)
Female
(28)
Male
(26)
Middle Aged
(24)
Biological And Medical Sciences
(19)
Dna Methylation
(19)
Tumors
(19)
Lung Cancer
(18)
Aged
(17)
Medical Sciences
(17)
Lung Neoplasms - Genetics
(15)
Carcinoma, Non-Small-Cell Lung - Genetics
(14)
Adult
(13)
Gene Expression Regulation, Neoplastic
(12)
Cell Line, Tumor
(10)
Prognosis
(10)
Cancer
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aberrant Methylation during Cervical Carcinogenesis

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer

Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non–small cell lung cancer brain metastases

The impact of COVID‐19 on cancer care of outpatients with low socioeconomic status

Influence of temporal muscle thickness on the outcome of radiosurgically treated patients with brain metastases from non-small cell lung cancer

Lung cancer: From single-gene methylation to methylome profiling

Homeopathic Treatment as an Add‐On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non‐Small Cell Lung Cancer: A Prospective, Randomized, Placebo‐Controlled, Double‐Blind, Three‐Arm, Multicenter Study

Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer

Non-interventional LUME-BioNIS study of nintedanib plus docetaxel after chemotherapy in adenocarcinoma non-small cell lung cancer: A subgroup analysis in patients with prior immunotherapy

SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness

Lung Cancer in Austria

DNA methylation of microRNA‐coding genes in non‐small‐cell lung cancer patients

Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non―Small Cell Lung Cancers

Neutrophil-to-Lymphocyte Ratio Is Superior to Other Leukocyte-Based Ratios as a Prognostic Predictor in Non–Small Cell Lung Cancer Patients with Radiosurgically Treated Brain Metastases Under Immunotherapy or Targeted Therapy

Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort

Homeopathic Treatment as an Add‐On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non‐Small Cell Lung Cancer: A Prospective, Randomized, Placebo‐Controlled, Double‐Blind, Three‐Arm, Multicenter Study

Genome-Wide Transcriptional Response to 5-Aza-2'-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells

Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery

Suchergebnisse filtern